JP2001521902A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521902A5
JP2001521902A5 JP2000518676A JP2000518676A JP2001521902A5 JP 2001521902 A5 JP2001521902 A5 JP 2001521902A5 JP 2000518676 A JP2000518676 A JP 2000518676A JP 2000518676 A JP2000518676 A JP 2000518676A JP 2001521902 A5 JP2001521902 A5 JP 2001521902A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
crosslinking agent
polymer
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000518676A
Other languages
English (en)
Japanese (ja)
Other versions
JP4452402B2 (ja
JP2001521902A (ja
Filing date
Publication date
Priority claimed from US08/964,956 external-priority patent/US5985938A/en
Application filed filed Critical
Publication of JP2001521902A publication Critical patent/JP2001521902A/ja
Publication of JP2001521902A5 publication Critical patent/JP2001521902A5/ja
Application granted granted Critical
Publication of JP4452402B2 publication Critical patent/JP4452402B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000518676A 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用 Expired - Lifetime JP4452402B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/964,956 US5985938A (en) 1997-11-05 1997-11-05 Method for reducing oxalate
US08/964,956 1997-11-05
PCT/US1998/022606 WO1999022744A1 (en) 1997-11-05 1998-10-26 Use of aliphatic polyamines for reducing oxalate

Publications (3)

Publication Number Publication Date
JP2001521902A JP2001521902A (ja) 2001-11-13
JP2001521902A5 true JP2001521902A5 (enExample) 2006-01-05
JP4452402B2 JP4452402B2 (ja) 2010-04-21

Family

ID=25509224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000518676A Expired - Lifetime JP4452402B2 (ja) 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用

Country Status (10)

Country Link
US (3) US5985938A (enExample)
EP (2) EP1044008B1 (enExample)
JP (1) JP4452402B2 (enExample)
AR (1) AR016001A1 (enExample)
AU (1) AU1364799A (enExample)
CA (1) CA2349620C (enExample)
DE (1) DE69833134T2 (enExample)
TW (1) TW585772B (enExample)
WO (1) WO1999022744A1 (enExample)
ZA (1) ZA989671B (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) * 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
ES2637020T3 (es) * 2001-04-18 2017-10-10 Genzyme Corporation Uso de polímero de amina para reducir la glucosa sérica
BR0209133A (pt) * 2001-04-18 2004-06-15 Genzyme Corp Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
EP1923064B1 (en) 2001-04-18 2017-06-28 Genzyme Corporation Use of amine polymer for lowering serum glucose
KR20040018359A (ko) * 2001-04-18 2004-03-03 젠자임 코포레이션 지방족 폴리아민으로 ｘ 증후군을 치료하는 방법
BR0209020A (pt) * 2001-04-18 2004-08-10 Genzyme Corp Composição farmacêutica de polialilamina
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
ATE499943T1 (de) * 2001-04-23 2011-03-15 Shire Int Licensing Bv Verwendung von lanthankarbonat zur prävention von nierensteinleiden
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
EP1446481B1 (en) * 2001-10-05 2008-05-21 OxThera, Inc., Materials and methods for reducing oxalate concentrations in fluids
US6600011B2 (en) * 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
ATE389684T1 (de) * 2001-10-09 2008-04-15 Genzyme Corp Verfahren zum reinigen und trocknen von polymerhydrogelen
AU2003282867A1 (en) * 2002-10-22 2004-05-13 Genzyme Corporation Amine polymers for promoting bone formation
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7385012B2 (en) * 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
DE112005000725B4 (de) 2004-03-30 2017-12-21 Relypsa, Inc. (n.d.Ges.d. Staates Delaware) Verfahren und Zusammensetzungen zur Behandlung von Ionen-Ungleichgewichten
WO2005110469A2 (en) * 2004-05-07 2005-11-24 Oxthera, Inc. Methods and compositions for reducing oxalate concentrations
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
WO2006072054A1 (en) * 2004-12-30 2006-07-06 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
KR101547925B1 (ko) 2005-09-15 2015-08-27 젠자임 코포레이션 아민 중합체에 대한 샤셋 제형
WO2007056405A2 (en) * 2005-11-08 2007-05-18 Genzyme Corporation Magnesium-containing polymers for the treatment of hyperphosphatemia
AU2005339139A1 (en) * 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
JP2009536246A (ja) * 2006-05-05 2009-10-08 ゲンズイメ コーポレーション ホスフェート捕捉剤としてのアミン縮合重合体
EP2043627A2 (en) * 2006-07-05 2009-04-08 Genzyme Corporation Iron(ii)-containing treatments for hyperphosphatemia
EP2043767B1 (en) 2006-07-14 2020-03-25 Wisconsin Alumni Research Foundation Adsorptive membranes for trapping viruses
CA2658338A1 (en) * 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
DK2046373T3 (da) * 2006-08-02 2013-05-27 Althea Technologies Inc Krystalliseret oxalatdecarboxylase og fremgangsmåder til anvendelse
WO2008042222A2 (en) 2006-09-29 2008-04-10 Genzyme Corporation Amide dendrimer compositions
JP5535638B2 (ja) * 2006-10-25 2014-07-02 ウィスコンシン アルムニ リサーチ ファンデイション リン酸塩吸収の低減方法
US20100143385A1 (en) * 2006-10-26 2010-06-10 Mark Cook Methods for reducing phosphate absorption
WO2008076242A1 (en) 2006-12-14 2008-06-26 Genzyme Corporation Amido-amine polymer compositions
EP2114376A1 (en) * 2007-02-23 2009-11-11 Genzyme Corporation Amine polymer compositions
WO2008109095A1 (en) * 2007-03-08 2008-09-12 Genzyme Corporation Sulfone polymer compositions
WO2008113364A2 (en) * 2007-03-20 2008-09-25 Recepticon Aps Amino derivatives to prevent nephrotoxicity and cancer
US20100166696A1 (en) * 2007-04-27 2010-07-01 Dhal Pradeep K Amido-amine dendrimer compositions
JP2011506449A (ja) * 2007-12-14 2011-03-03 ジェンザイム コーポレーション コーティング医薬組成物
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
WO2009154747A1 (en) * 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
JPWO2010123039A1 (ja) * 2009-04-21 2012-10-25 株式会社医学生物学研究所 生物学的材料の不動化を行うための組成物
WO2014113648A1 (en) 2013-01-18 2014-07-24 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
CA2906501A1 (en) * 2013-03-15 2014-09-25 Genzyme Corporation Sequestrants of advanced glycation end product (age) precursors
US11077238B2 (en) 2013-06-07 2021-08-03 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
US10435528B2 (en) 2013-09-17 2019-10-08 Aquanano Llc High-capacity anion exchange materials
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
AU2016244121B2 (en) 2015-04-02 2020-11-05 Orenzymes Llc High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
GB201718803D0 (en) * 2017-11-14 2017-12-27 Phoenix Molecular Pte Ltd Method for isolation of nucleic acids
WO2019236858A1 (en) * 2018-06-06 2019-12-12 The Board Of Trustees Of The University Of Illinois Zwitterionic biocompatible polymers, methods, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198396A (en) * 1974-07-03 1980-04-15 Warren-Teed Laboratories, Inc. Dissolution of gallstones
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
JPS60202869A (ja) * 1984-03-26 1985-10-14 Ajinomoto Co Inc 大環状ポリアミン誘導体及びその用途
DE3727082A1 (de) * 1987-08-14 1989-02-23 Goedecke Ag Pharmazeutische zubereitungen zur behandlung der urolithiasis
US5244913A (en) * 1991-11-19 1993-09-14 Baxter International Inc. Compositions and methods for dissolving body calculi
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
ATE361335T1 (de) * 1996-10-23 2007-05-15 Dow Global Technologies Inc Wasserlösliche polymere für die verminderung der absorption von diätetikem phosphat oder oxalat
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate

Similar Documents

Publication Publication Date Title
JP2001521902A5 (enExample)
JP2001521890A5 (enExample)
WO1999033452A3 (en) Amine-containing copolymers as bile acid sequestrants
JP2004535384A5 (enExample)
JP2004528332A5 (enExample)
JP2005533531A5 (enExample)
JP2004526778A5 (enExample)
JPH11152398A5 (enExample)
CA2444046A1 (en) Use of colesevelam in reducing serum glucose
EP1645278A3 (en) Use of aliphatic polyamines for reducing oxalate
EP0970819A3 (en) Ink-jet recording element containing polymeric mordant
EP0827027A3 (en) Curable compositions
JP2004520473A5 (enExample)
JP2003500522A5 (enExample)
KR950031088A (ko) 교차 결합된 음이온 교환 입자 및 그 제조 방법
JP2005517062A5 (enExample)
DE69825619D1 (de) Strikt alternierende poly(alkylenoxid)copolymere
CA1237229A (en) Method for making conductive member for skin contact electrode containing sulfonated polymer material
JP2001509529A5 (enExample)
EP0473793A4 (en) Curable composition
CA2481365A1 (en) Occlusive composition comprising a poly (2-cyanoacrylate) monomer
JP2003518152A5 (enExample)
JP2008543602A5 (enExample)
EP1138730A3 (en) Aqueous polymer emulsions
JP2006503144A5 (enExample)